Skip Navigation


IJE Advance Access originally published online on May 15, 2009
International Journal of Epidemiology 2009 38(6):1612-1621; doi:10.1093/ije/dyp208
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
38/6/1612    most recent
dyp208v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Edmonds, A.
Right arrow Articles by Behets, F.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Edmonds, A.
Right arrow Articles by Behets, F.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Published by Oxford University Press on behalf of the International Epidemiological Association © The Author 2009; all rights reserved.

Anti-retroviral therapy reduces incident tuberculosis in HIV-infected children

Andrew Edmonds1,*, Jean Lusiama2, Sonia Napravnik1,3, Faustin Kitetele3, Annelies Van Rie1 and Frieda Behets1,3

1 The University of North Carolina at Chapel Hill, Department of Epidemiology, Chapel Hill, NC, USA.
2 The University of Kinshasa, School of Public Health, Kinshasa, Democratic Republic of Congo.
3 The University of North Carolina at Chapel Hill, School of Medicine, Chapel Hill, NC, USA.

* Corresponding author. The University of North Carolina at Chapel Hill, Department of Epidemiology, Chapel Hill, NC, USA. E-mail: aedmonds{at}email.unc.edu


   Abstract

Background We aimed to estimate the effect of anti-retroviral therapy (ART) on incident tuberculosis (TB) in a cohort of HIV-infected children.

Methods We analysed data from ART-naïve, TB disease-free children enrolled between December 2004 and April 2008 into an HIV care program in Kinshasa, Democratic Republic of Congo. To estimate the effect of ART on TB incidence while accounting for time-dependent confounders affected by exposure, a Cox proportional hazards marginal structural model was used.

Results 364 children contributed 596.0 person-years of follow-up. At baseline, the median age was 6.9 years; 163 (44.8%) were in HIV clinical stage 3 or 4. During follow-up, 242 (66.5%) children initiated ART and 81 (22.3%) developed TB. At TB diagnosis, 41 (50.6%) were receiving ART. The TB incidence rate in those receiving ART was 10.2 per 100 person-years [95% confidence interval (CI) 7.4–13.9] compared with 20.4 per 100 person-years (95% CI 14.6–27.8) in those receiving only primary HIV care. TB incidence decreased with time on ART, from 18.9 per 100 person-years in the first 6 months to 5.3 per 100 person-years after 12 months of ART. The model-estimated TB hazard ratio for ART was 0.51 (95% CI 0.27–0.94).

Conclusions For HIV-infected children in TB-endemic areas, ART reduces the hazard of developing TB by 50%.


Keywords HIV, tuberculosis, anti-retroviral therapy, children, marginal structural model

Accepted 9 April 2009


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Int J EpidemiolHome page
A. Boulle and B. Eley
Commentary: Reducing HIV-associated tuberculosis in children
Int. J. Epidemiol., December 1, 2009; 38(6): 1621 - 1623.
[Full Text] [PDF]


Home page
Int J EpidemiolHome page
L. Fenner, M. Egger, and S. Gagneux
Annie Darwin's death, the evolution of tuberculosis and the need for systems epidemiology
Int. J. Epidemiol., December 1, 2009; 38(6): 1425 - 1428.
[Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.